Our Science
Selected publications
Dugan IL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, et al. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates. Ann Neurol. 2014;76 (3):393-402.
Dugan IL, Lovett EG, Quick KI, Lotharius J, Lin TI, O’Malley KI. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord. 2001 Jul 1;7 (3):243-6.
Ruden JB, Quick KL, Gonzales ER, Shah AR, Park TS, Kennedy N, et al. Reduction of Leukocyte Microvascular Adherence and Preservation of Blood-Brain Barrier Function by Superoxide-Lowering Therapies in a Piglet Model of Neonatal Asphyxia. Front Neurol. 2019;10:447.
Dugan IL, Iuretsky DM, Du C, Lobner D, Wheeler M, Almli CR, et al. Carboxyfullerenes as neuroprotective agents. Proc Nati Acad Sci. 1997 Aug 19;94 (17): 9434-9.
Ali SS, Hardt JI, Quick KI, Sook Kim-Han J, Erlanger BF, Huang I ting, et al. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med. 2004 Oct 15;37 (8):1191-202.
Get in touch for more information
© 2024 Etheros Pharmaceuticals.